Tags

Type your tag names separated by a space and hit enter

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vaccine. 2010 Oct 21; 28(45):7248-55.V

Abstract

The United States (US) influenza A (H1N1) 2009 monovalent (2009-H1N1) vaccination program began in October 2009. Reports to the vaccine adverse event reporting system (VAERS), a US spontaneous reporting system, were reviewed to identify potential rare events or unusual adverse event (AE) patterns after 2009-H1N1 vaccination. The adverse event profile after 2009-H1N1 vaccine in VAERS (∼10,000 reports) was consistent with that of seasonal influenza vaccines, although the reporting rate was higher after 2009-H1N1 than seasonal influenza vaccines, this may be, at least in part, a reflection of stimulated reporting. Death, Guillain-Barré syndrome and anaphylaxis reports after 2009-H1N1 vaccination were rare (each <2 per million doses administered).

Authors+Show Affiliations

Immunization Safety Office, Division of Health Care Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. bno1@cdc.govNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

20850534

Citation

Vellozzi, Claudia, et al. "Adverse Events Following Influenza a (H1N1) 2009 Monovalent Vaccines Reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010." Vaccine, vol. 28, no. 45, 2010, pp. 7248-55.
Vellozzi C, Broder KR, Haber P, et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010;28(45):7248-55.
Vellozzi, C., Broder, K. R., Haber, P., Guh, A., Nguyen, M., Cano, M., Lewis, P., McNeil, M. M., Bryant, M., Singleton, J., Martin, D., & DeStefano, F. (2010). Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine, 28(45), 7248-55. https://doi.org/10.1016/j.vaccine.2010.09.021
Vellozzi C, et al. Adverse Events Following Influenza a (H1N1) 2009 Monovalent Vaccines Reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010 Oct 21;28(45):7248-55. PubMed PMID: 20850534.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. AU - Vellozzi,Claudia, AU - Broder,Karen R, AU - Haber,Penina, AU - Guh,Alice, AU - Nguyen,Michael, AU - Cano,Maria, AU - Lewis,Paige, AU - McNeil,Michael M, AU - Bryant,Marthe, AU - Singleton,James, AU - Martin,David, AU - DeStefano,Frank, Y1 - 2010/09/16/ PY - 2010/08/24/received PY - 2010/08/31/revised PY - 2010/09/09/accepted PY - 2010/9/21/entrez PY - 2010/9/21/pubmed PY - 2011/1/25/medline SP - 7248 EP - 55 JF - Vaccine JO - Vaccine VL - 28 IS - 45 N2 - The United States (US) influenza A (H1N1) 2009 monovalent (2009-H1N1) vaccination program began in October 2009. Reports to the vaccine adverse event reporting system (VAERS), a US spontaneous reporting system, were reviewed to identify potential rare events or unusual adverse event (AE) patterns after 2009-H1N1 vaccination. The adverse event profile after 2009-H1N1 vaccine in VAERS (∼10,000 reports) was consistent with that of seasonal influenza vaccines, although the reporting rate was higher after 2009-H1N1 than seasonal influenza vaccines, this may be, at least in part, a reflection of stimulated reporting. Death, Guillain-Barré syndrome and anaphylaxis reports after 2009-H1N1 vaccination were rare (each <2 per million doses administered). SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/20850534/Adverse_events_following_influenza_A__H1N1__2009_monovalent_vaccines_reported_to_the_Vaccine_Adverse_Event_Reporting_System_United_States_October_1_2009_January_31_2010_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(10)01331-9 DB - PRIME DP - Unbound Medicine ER -